Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trial Article

sustainable development goals

publication date

  • May 7, 2024

webpage

published in

keywords

  • basophils
  • benralizumab
  • chronic rhinosinusitis with nasal polyps
  • eosinophils
  • interleukin-5

start page

  • 1952

end page

  • 1963

volume

  • 90

issue

  • 8